Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwan R Lee

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
AIDS (London, England)|February 7, 2020
Associations of antiretroviral therapy and comorbidities with neurocognitive outcomes in HIV-1-infected patientsUma Siangphoe, Kellie J Archer, Christopher Nguyen, et al.
Proteomics|September 16, 2003
Megavariate data analysis of mass spectrometric proteomics data using latent variable projection methodKwan R Lee, Xiwu Lin, Daniel C Park, et al.
Drug Safety|October 30, 2014
Methodology to assess clinical liver safety dataMichael Merz, Kwan R Lee, Gerd A Kullak-Ublick, et al.
Pharmacoepidemiology and Drug Safety|January 10, 2013
A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical dataDaniel Parks, Xiwu Lin, Jeffery L Painter, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
AIDS (London, England)|February 7, 2020
Associations of antiretroviral therapy and comorbidities with neurocognitive outcomes in HIV-1-infected patientsUma Siangphoe, Kellie J Archer, Christopher Nguyen, et al.
Proteomics|September 16, 2003
Megavariate data analysis of mass spectrometric proteomics data using latent variable projection methodKwan R Lee, Xiwu Lin, Daniel C Park, et al.
Drug Safety|October 30, 2014
Methodology to assess clinical liver safety dataMichael Merz, Kwan R Lee, Gerd A Kullak-Ublick, et al.
Pharmacoepidemiology and Drug Safety|January 10, 2013
A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical dataDaniel Parks, Xiwu Lin, Jeffery L Painter, et al.
Pageof 1